- This study was sponsored by the vaccine manufacturer, Wyeth-Lederle.
- Efficacy of PCV7 against pneumonia is to be reported separately.
- PCV7 appears to be safe and may be cost-effective for healthy infants
and children. Please see previous CATs regarding these topics
(Ada Lin, 3/23/00; Susan
S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity
of heptavalent pneumococcal conjugate vaccine in children. Pediatric
Infectious Disease Journal 2000; 19:187-195.
AAP Committee on Infectious Diseases. Policy Statement:
Recommendations for the Prevention of Pneumococcal Infections, Including
the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide
Vaccine, and Antibiotic Prophylaxis. Pediatrics 2000; 106:362-366.